<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/036293</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Systems Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypic spandrel: absolute discrimination and ligand antagonism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Francois</surname><given-names>Paul</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Johnson</surname><given-names>Kyle A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Saunders</surname><given-names>Laura N</given-names></name>
</contrib>
<aff id="a1"><institution>Physics Department, McGill University</institution>, Montreal, Quebec, <country>Canada</country> H3A 2T8</aff>
</contrib-group>
<pub-date pub-type="epub"><year>2016</year></pub-date>
<elocation-id>036293</elocation-id>
<history>
<date date-type="received"><day>08</day><month>1</month><year>2016</year></date>
<date date-type="accepted"><day>10</day><month>1</month><year>2016</year></date>
</history>
<permissions><copyright-statement>&#x00A9; 2016, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="036293.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<p>We consider the general problem of absolute discrimination between categories of ligands irrespective of their concentration. An instance of this problem is immune discrimination between self and not-self. We connect this problem to biochemical adaptation, and establish that ligand antagonism - the ability of sub threshold ligands to negatively impact response - is a necessary consequence of absolute discrimination.Thus antagonism constitutes a &#x201C;phenotypic spandrel&#x201D;: a phenotype existing as a necessary by-product of another phenotype. We exhibit a simple analytic model of absolute discrimination displaying ligand antagonism, where antagonism strength is linear in distance from threshold. This contrasts with proofreading based models, where antagonism vanishes far from threshold and thus displays an inverted hierarchy of antagonism compared to simple model. The phenotypic spandrel studied here is expected to structure many decision pathways such as immune detection mediated by TCRs and FceRIs.</p>
</abstract>
<counts>
<page-count count="7"/>
</counts>
</article-meta>
</front>
<body>
<p>Recent works in quantitative evolution combined to mathematical modelling have shown that evolution of biological structures is constrained by selected phenotypes in strong unexpected ways. Trade-off between different functionalities are major forces shaping evolution of complex phenotypes moving on evolutionary Pareto fronts [<xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref>]. <italic>In silico</italic> evolution of phenotypic models of gene networks [<xref ref-type="bibr" rid="c3">3</xref>] have further shown that selection of complex phenotypes leads to apparition of other traits that have not been explicitly selected for. For instance, a clock naturally appears when selecting for stripe formation in a model of segmentation evolution [<xref ref-type="bibr" rid="c4">4</xref>], or ligand antagonism when selecting for a model of immune recognition [<xref ref-type="bibr" rid="c5">5</xref>]. This is reminiscent of the architectural image of &#x201C;evolutionary spandrels&#x201D; proposed by Gould and Lewontin [<xref ref-type="bibr" rid="c6">6</xref>]. They argued that many biological properties are necessary by-products of more fundamental adaptive traits, that can be further elaborated by evolution (leading to the notion of &#x201C;exaptation&#x201D;[<xref ref-type="bibr" rid="c7">7</xref>]).</p>
<p>An important biological example is the absolute discrimination between different ligand &#x201C;qualities&#x201D;, an instance being early immune recognition [<xref ref-type="bibr" rid="c8">8</xref>&#x2013;<xref ref-type="bibr" rid="c11">11</xref>]. T cells have to recognize minute concentrations of not-self while being insensitive to overwhelming concentration of self ligands. The parameter discriminating self from not-self is the ligand dissociation time <italic>&#x03C4;</italic> [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c13">13</xref>] to T cell receptors (TCRs), defining the so-called &#x201C;life-time dogma&#x201D; [<xref ref-type="bibr" rid="c9">9</xref>]. In evolutionary simulations [<xref ref-type="bibr" rid="c5">5</xref>], the phenomenon of absolute discrimination is not achieved without detrimental ligand antagonism: an experimental &#x201C;dog in the manger&#x201D; effect in which ligands unable to trigger response prevent agonists to do so [<xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c15">15</xref>].</p>
<p>Here, we show mathematically that ligand antagonism is a necessary by-product of absolute discrimination. We thus qualify antagonism as a &#x201C;phenotypic spandrel&#x201D;: a phenotype existing as a necessary by-product of another phenotype. We exhibit a generic simple model for antagonism, and further show how addition of proofreading steps leads to an &#x201C;inverted&#x201D; hierarchy of antagonism that is <italic>not</italic> a generic feature of the antagonism spandrel.</p>
<p>We consider a family of biochemical ligands, with different quantitative properties encoded by a continuous parameter <italic>&#x03C4;</italic>, subsequently called &#x201C;ligand quality&#x201D;. Ideal absolute discrimination is observed when cells successfully discriminate between two categories of ligands, above and below critical quality <italic>&#x03C4;<sub>c</sub></italic>, irrespective of ligand quantity <italic>L</italic>. An idealized response diagram for absolute discrimination in (<italic>L</italic>, <italic>&#x03C4;</italic>) plane defines a vertical &#x201C;discrimination line&#x201D; at <italic>&#x03C4;<sub>c</sub></italic> (<xref ref-type="fig" rid="fig1">Fig1 A</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure"><label>FIG. 1.</label>
<caption><p>(A). Sketch of absolute discrimination for a single ligand type in (<italic>L, &#x03C4;</italic>) plane. Discrimination line corresponding to <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic> is in red. (B). Sketch of absolute discrimination for mixtures, adding a second type of ligands with quality <italic>&#x03C4;<sub>2</sub></italic>, with <italic>L<sub>1</sub>, L<sub>2</sub></italic> ligand concentrations represented by a vertical axis. The discrimination line for <italic>&#x03C4;</italic><sub>1</sub> &#x003D; <italic>&#x03C4;</italic><sub>2</sub> &#x003D; <italic>&#x03C4;<sub>c</sub></italic> is vertical and satisfies <xref ref-type="disp-formula" rid="eqn1">equation 1</xref>. Red planes correspond to mixtures of agonist where necessary <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline2.gif"/></alternatives></inline-formula>. (C). Intuitive explanation of antagonism (see main text). Relative height of mixtures correspond to values of <italic>C</italic>. For absolute discrimination, any amount of ligand at <italic>&#x03C4;<sub>c</sub></italic> is on the discrimination line, so that if <italic>&#x03C4; &#x003C; &#x03C4;<sub>c</sub></italic>, contribution of <italic>L</italic><sub>2</sub> ligands is negative.</p></caption>
<graphic xlink:href="036293_fig1.tif"/>
</fig>
<p>We model absolute discrimination using biochemical networks with continuous, single-valued variables, at steady state, in a way similar to most phenotypic models of early immune recognition such as the ones reviewed in [<xref ref-type="bibr" rid="c10">10</xref>]. Discrimination models are often based on comparison of a downstream protein <italic>C</italic> concentration to a threshold &#x0398;, i.e. response is triggered when <italic>C &#x2265;</italic> &#x0398;. For ligands at <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic> from <xref ref-type="fig" rid="fig1">Figure 1A</xref>, by continuity we thus necessarily have on the discrimination line</p>
<disp-formula id="eqn1"><alternatives><graphic xlink:href="036293_eqn1.gif"/></alternatives></disp-formula>
<p><xref ref-type="disp-formula" rid="eqn1">Equation 1</xref> expresses that <italic>C</italic> is independent from the concentration of ligand <italic>L:</italic> technically <italic>C</italic> is a biochemically adaptive variable at <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic> [<xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c17">17</xref>].</p>
<p><italic>In vivo</italic>, cells are exposed to complex mixtures of ligands interacting with receptors at the surface of a single cell. Consider now the problem of absolute discrimination in mixtures, sketched on <xref ref-type="fig" rid="fig1">Fig 1B</xref>. Assume that on the discrimination line <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic>, we change the quality of a fraction <italic>r</italic> of ligands from <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline1.gif"/></alternatives></inline-formula>. Assuming for <italic>d&#x03C4;</italic> &#x003E; 0 a mixture of (1&#x2212;<italic>r)L</italic> ligands at <italic>&#x03C4;<sub>c</sub></italic> with <italic>rL</italic> ligands at <italic>&#x03C4;<sub>c</sub> &#x002B; d&#x03C4;</italic> yields response so that for the corresponding output variable
<disp-formula id="eqn2"><alternatives><graphic xlink:href="036293_eqn2.gif"/></alternatives></disp-formula></p>
<p>We can then Taylor expand this expression with respect to <italic>d&#x03C4;</italic> to define
<disp-formula id="eqn3"><alternatives><graphic xlink:href="036293_eqn3.gif"/></alternatives></disp-formula>
and then combining with <xref ref-type="disp-formula" rid="eqn1">equations 1</xref>-<xref ref-type="disp-formula" rid="eqn2">2</xref> we get <italic>A</italic>(<italic>L, r, &#x03C4;<sub>c</sub></italic>) &#x003E; 0. Flipping the sign in front of <italic>d&#x03C4;</italic> to consider another type of ligand mixture (1 - <italic>r)L</italic> ligands at <italic>T<sub>C</sub></italic> and <italic>rL</italic> ligands at <italic>&#x03C4;<sub>c</sub></italic> &#x2212; <italic>d&#x03C4;</italic>, we thus have
<disp-formula id="eqn4"><alternatives><graphic xlink:href="036293_eqn4.gif"/></alternatives></disp-formula></p>
<p>This inequality is valid for any <italic>r</italic>, <italic>L</italic>. We then change our variables to define the mixture as <italic>L<sub>1</sub> &#x003D; L(1 - r</italic>) agonist ligands mixed with <italic>L<sub>2</sub> &#x003D; rL</italic> sub threshold ligands (i.e. <italic>r &#x003D; L<sub>2</sub></italic>/(<italic>L<sub>1</sub> &#x002B; L<sub>2</sub></italic>),<italic>L &#x003D; L<sub>1</sub> &#x002B; L<sub>2</sub></italic>). Furthermore from <xref ref-type="disp-formula" rid="eqn1">equation 1</xref> for any r value we have <italic>C</italic>(<italic>L, &#x03C4;<sub>c</sub></italic>) &#x003D; <italic>C</italic>((1 &#x2212;<italic>r</italic>)<italic>L, &#x03C4;<sub>c</sub></italic>) &#x003D; <italic>&#x0398;</italic>, so substituting in right-hand side of 4 we get:</p>
<disp-formula id="eqn5"><alternatives><graphic xlink:href="036293_eqn5.gif"/></alternatives></disp-formula>
<p>This latter expression is the exact definition of antagonism: as soon as sub-threshold ligands <italic>L<sub>2</sub></italic> are added in presence of critical agonist ligands <italic>L</italic><sub>1</sub>, the output variable is decreased with respect to the case of pure <italic>L</italic><sub>1</sub>, and thus if decision is based on thresholding of output, response disappears.</p>
<p>An intuitive explanation of the above reasoning can be made. Considering a mixture of ligands (<italic>L<sub>n</sub></italic>) of different qualities (<italic>&#x03C4;<sub>n</sub></italic>), output <italic>C</italic> is an increasing function of both <italic>L</italic> and <italic>&#x03C4;</italic> for models with monotonic response curves such as kinetic proofreading [<xref ref-type="bibr" rid="c18">18</xref>]. In such models, starting from a critical ligand concentration <italic>L<sub>1</sub></italic> triggering response (i.e. <italic>C</italic>(<italic>L</italic><sub>1</sub>, <italic>&#x03C4;<sub>c</sub></italic>) &#x003D; <italic>&#x0398;</italic>), any addition of ligands <italic>L<sub>2</sub></italic> gives higher output value and response is maintained. Addition of <italic>L<sub>2</sub></italic> ligands with critical quality <italic>&#x03C4;<sub>c</sub></italic> gives higher output than addition of same quantity <italic>L<sub>2</sub></italic> of ligands with lower quality <italic>&#x03C4; &#x003C; &#x03C4;<sub>c</sub></italic> (symbolized by a downward arrow in the upper part of <xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p>
<p>Considering now absolute discrimination and again addition of <italic>L<sub>2</sub></italic> ligands on <xref ref-type="fig" rid="fig1">Figure 1C</xref>, the constraint encoded by <xref ref-type="disp-formula" rid="eqn1">equation 1</xref> means that addition of extra <italic>L<sub>2</sub></italic> ligands of quality <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic> does not impact output value. But if we require that mixtures of agonists trigger response (expressed by <xref ref-type="disp-formula" rid="eqn2">equation 2</xref>), it means that output sill is a monotonic function of <italic>&#x03C4;</italic>. Thus if ligand quality of the extra <italic>L<sub>2</sub></italic> ligands is lowered, we expect that a negative contribution similar to the monotonic example (with <italic>&#x03C4; &#x003C; &#x03C4;<sub>c</sub></italic>) appears (symbolized by a downward arrow in the lower part of <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Thus response would now be below threshold of activation, corresponding to antagonism.</p>
<p>Antagonism here is a direct consequence of biochemical adaptation at <italic>&#x03C4;</italic> &#x003D; <italic>&#x03C4;<sub>c</sub></italic>. By continuity, antagonism is expected for ligands not necessarily tuned on the critical line <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic>. Furthermore, adaptation does not necessarily have to be perfect: non-monotonic response curves [<xref ref-type="bibr" rid="c19">19</xref>], with <italic>C</italic> varying around &#x0398;, essentially approximate well adaptation necessary for absolute discrimination and display antagonism [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c20">20</xref>]. At least two examples of absolute discrimination/antagonism are offered in the immune context. For early immune recognition mediated by TCRs, agonists simultaneously presented with ligands just below threshold fail to trigger response, while agonists alone do [<xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c21">21</xref>]. For FceRIs mediated response in mast cells [<xref ref-type="bibr" rid="c14">14</xref>], a very similar &#x201C;dog in the manger&#x201D; effect is observed where low affinity antagonists titrate the Lyn kinase responsible for proofreading steps (exactly like adaptive sorting evolved in [<xref ref-type="bibr" rid="c5">5</xref>]).</p>
<p>Further categorization of absolute discrimination mechanisms combined to antagonism is possible. A &#x201C;homeostatic model&#x201D; (<xref ref-type="fig" rid="fig2">Figure 2</xref>) is inspired by a ligand-receptor adaptive network evolved in [<xref ref-type="bibr" rid="c16">16</xref>].</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure"><label>FIG. 2.</label>
<caption><p>(A). Sketch of homeostatic network considered in main text, with corresponding equations. For simulations we use &#x03BA; &#x003D; 10<sup>&#x2212;3</sup>, and define <italic>&#x03C4;<sub>c</sub></italic> &#x003D; &#x0398; &#x003D; 4. (B). Color map of output <italic>C</italic> values in the (<italic>L, &#x03C4;</italic>) plane, ligand quality is plotted in units of <italic>&#x03C4;<sub>c</sub></italic>.(B) Discrimination line (solid red) is vertical similar to <xref ref-type="fig" rid="fig1">figure 1 A</xref> (C) Color map of output <italic>C</italic> values in plane (L1, <italic>d&#x03C4;</italic>) for mixtures of L2 &#x003D; 10 ligands, quality <italic>&#x03C4;</italic>&#x002B;<italic>d&#x03C4;</italic>, with <italic>L1</italic> ligands, quality <italic>&#x03C4;<sub>c</sub></italic>. This plane is orthogonal to the plane displayed in panel B. Threshold line is vertical at <italic>d&#x03C4;</italic> &#x003D; 0 similar to <xref ref-type="fig" rid="fig1">figure 1 B</xref>.</p></caption>
<graphic xlink:href="036293_fig2.tif"/>
</fig>
<p>Receptors are produced with fixed rate (rescaled to 1). Receptor-ligand complexes (<italic>C<sub>i</sub></italic>) trigger response but are degraded with time-scale <italic>&#x03C4;<sub>i</sub></italic>, defining quality of ligands (see <xref ref-type="fig" rid="fig2">Figure 2 A</xref>). Steady state equations for homeostatic model is for mixture {(<italic>L<sub>n</sub>,&#x03C4;<sub>n</sub></italic>)}</p>
<disp-formula id="eqn6"><alternatives><graphic xlink:href="036293_eqn6.gif"/></alternatives></disp-formula>
<p>When only one type of ligand (<italic>L</italic>, <italic>&#x03C4;<sub>c</sub></italic>) is present, <italic>C<sub>tot</sub> &#x003D; &#x03C4;<sub>c</sub></italic> is adaptive (i.e. independent from <italic>L</italic>) as expected. At steady state, <italic>R</italic> is inversely proportional to total ligand concentration presented irrespective of their <italic>&#x03C4;s</italic>. Importantly, this is not due to a titration effect of a fixed pool: <italic>R dynamically</italic> buffers any ligand addition, so that steady state output <italic>C<sub>tot</sub></italic> is a weighted linear combination of <italic>&#x03C4;<sub>n</sub></italic>s in 6. Such combination is always inferior to the maximum of <italic>&#x03C4;<sub>n</sub></italic>, so if such maximum indeed is <italic>&#x03C4;<sub>c</sub></italic>, antagonism ensues. If we consider the mixture of <italic>L</italic><sub>1</sub> ligands (critical time <italic>&#x03C4;<sub>c</sub></italic>) with <italic>L<sub>2</sub></italic> ligands (<italic>&#x03C4;<sub>c</sub></italic> - <italic>d&#x03C4;</italic>) we get
<disp-formula id="eqn7"><alternatives><graphic xlink:href="036293_eqn7.gif"/></alternatives></disp-formula>
with <italic>r &#x003D; L<sub>2</sub>/L<sub>2</sub>&#x002B;L<sub>1</sub></italic> as before. This contribution is exact and linear in <italic>d&#x03C4;</italic> at all orders.</p>
<p><xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2">C</xref> show values of <italic>C<sub>to</sub>t</italic> for pure ligands and mixture, with vertical discrimination lines at <italic>&#x03C4;<sub>c</sub></italic>. This simple model thus represents a perfect implementation of the principles sketched in <xref ref-type="fig" rid="fig1">Figure 1</xref> [<xref ref-type="bibr" rid="c22">22</xref>]. Interestingly, antagonism strength is proportional to the deviation of antagonists&#x2019; quality <italic>d&#x03C4;</italic> from <italic>&#x03C4;<sub>c</sub></italic> (<xref ref-type="disp-formula" rid="eqn7">equation 7</xref>). In particular, antagonism is very weak for ligand quality close to <italic>&#x03C4;<sub>c</sub></italic> and gets stronger as quality of ligands gets further below threshold.</p>
<p>This hierarchy of antagonism is completely opposite to what we know of immune examples, where antagonism is maximum for ligands close to <italic>&#x03C4;<sub>c</sub></italic>, and vanishes for small <italic>&#x03C4;<sub>s</sub></italic>, corresponding to &#x201C;self [<xref ref-type="bibr" rid="c15">15</xref>]. Many immune models are based on kinetic proofreading [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c18">18</xref>], proposed to be mediated by kinetic segregation [<xref ref-type="bibr" rid="c23">23</xref>]. Receptors exist in different phosphorylation states (<italic>C<sub>j</sub>s</italic>, <xref ref-type="fig" rid="fig3">Figure 3 A</xref>). Transition rates between states are functions of internal variables (notation M), accounting for all signalling inside cells (kinases, phosphatases), and assumed to diffuse freely and rapidly. M values depend on the total occupancy of some <italic>C<sub>j</sub>s</italic>. Downstream decision is usually assumed to be effectively controlled by thresholding on one state <italic>C<sub>n<sub>R</sub></sub></italic>.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure"><label>FIG. 3.</label>
<caption><p>(A) General topology considered for proofreading-based models, with shared internal variables <bold>M</bold>. (B) Adaptive sorting topology and response, with colormap for output <italic>C<sub><sc>n</sc></sub></italic> for pure ligands and mixtures. Equations and parameters are in Appendix. We fix <italic>L</italic><sub>2</sub> &#x003D; 10<sup>3</sup> ligands for mixtures, using similar conventions to <xref ref-type="fig" rid="fig2">Figure 2C</xref>. Threshold &#x0398; for discrimination line was chosen so that response is triggered by <italic>L</italic><sub>1</sub> &#x223C; 500 ligands at <italic>&#x03C4;<sub>c</sub></italic>. For <italic>d&#x03C4;</italic> &#x223C; &#x2212; 1, downward folding of both response line and green region compared to <xref ref-type="fig" rid="fig2">Figure 2 C</xref> indicates decreased antagonism. (C) Immune model with same conventions as (B), equations and parameters are in Appendix</p></caption>
<graphic xlink:href="036293_fig3.tif"/>
</fig>
<p>Using standard assumptions, it is easy to show (Appendix) that for this class of models, the number of receptor states <italic>Cj</italic> bound to ligands (<italic>L</italic>, <italic>&#x03C4;</italic>) is:
<disp-formula id="eqn8"><alternatives><graphic xlink:href="036293_eqn8.gif"/></alternatives></disp-formula>
i.e. we can decouple influence of ligands into a linear contribution (<italic>L</italic>), and an indirect one (<italic>c<sub>j</sub></italic>) purely due to internal variables. In the context of absolute discrimination <xref ref-type="disp-formula" rid="eqn1">equation 1</xref> imposes that <italic>C<sub>n<sub>R</sub></sub></italic> is tuned to threshold &#x0398; irrespective of <italic>L</italic> at <italic>&#x03C4;<sub>c</sub></italic>. <xref ref-type="disp-formula" rid="eqn8">Equation 8</xref> thus constrains <italic>C<sub>n<sub>R</sub></sub></italic> to be inversely proportional to <italic>L</italic> at <italic>&#x03C4;<sub>c</sub></italic>, very much like <italic>R</italic> in homeostatic model. Thus internal variables necessary implement an incoherent feedforward loop [<xref ref-type="bibr" rid="c24">24</xref>] and/or a negative feedback via <italic>c<sub>n</sub><sub>R</sub></italic>. This is observed in adaptive sorting models for high ligands <italic>L</italic> [<xref ref-type="bibr" rid="c5">5</xref>] (vertical asymptotic discrimination line on <xref ref-type="fig" rid="fig3">Figure 3 B</xref>). Immune model from [<xref ref-type="bibr" rid="c20">20</xref>] only locally approximates this adaptive constraint (<xref ref-type="fig" rid="fig3">Figure 3 C</xref>, high values of <italic>L</italic>).</p>
<p>An important difference with homeostatic model is that transition rates between variables depend explicitly on <italic>&#x03C4;</italic> in proofreading models. It is informative to consider an Ansatz with only one internal variable <italic>M</italic> and separable influence of <italic>&#x03C4;</italic> so that the contribution to the output variable from ligands (<italic>L</italic>, <italic>&#x03C4;</italic>) is
<disp-formula id="eqn9"><alternatives><graphic xlink:href="036293_eqn9.gif"/></alternatives></disp-formula>
with <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline3.gif"/></alternatives></inline-formula> at steady state for mixture {<italic>L<sub>1</sub>,&#x03C4;<sub>i</sub></italic>}. <italic>&#x03B2;</italic> &#x003D; &#x2212;1 gives perfect adaptation but different values of <italic>&#x03B2;</italic> can give realistic biological effects such as loss of response at high ligand concentration as observed in [<xref ref-type="bibr" rid="c20">20</xref>]. Function <italic>f</italic>(<italic>&#x03C4;</italic>) typically corresponds to the &#x201C;direct&#x201D; influence due to the main proofreading cascade (<italic>n<sub>R</sub></italic> steps), while <italic>g</italic> encodes internal effects triggered by another proofreading step (<italic>m</italic>). Linear contribution to antagonism can be directly computed. We Taylor expand <italic>C<sub>tot</sub></italic>({(1 &#x2212; <italic>r</italic>)<italic>L</italic>,<italic>&#x03C4;<sub>c</sub></italic>;<italic>rL</italic>,<italic>&#x03C4;<sub>c</sub></italic> &#x002B; <italic>d&#x03C4;</italic>})&#x2212;<italic>C</italic>(<italic>L</italic>,<italic>&#x03C4;<sub>c</sub></italic>) to get the linear term at order d<italic>&#x03C4;</italic>:</p>
<disp-formula id="eqn10"><alternatives><graphic xlink:href="036293_eqn10.gif"/></alternatives></disp-formula>
<p>For &#x03B2; <italic>&#x003D;-1</italic>, this term is very similar to antagonism expression for homeostatic model (<xref ref-type="disp-formula" rid="eqn7">equation 7</xref>), with extra <italic>&#x03C4;</italic> dependency coming from f, <italic>g</italic>. If we impose that mixture of agonists trigger response (<xref ref-type="disp-formula" rid="eqn2">equation 2</xref>), we necessary have <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline4.gif"/></alternatives></inline-formula>. If <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline5.gif"/></alternatives></inline-formula> and <italic>g</italic> &#x221D; <italic>&#x03C4;</italic><sup>m&#x002B;1</sup> which is approximately the case for adaptive sorting (see Appendix), we thus have n<sub>R</sub> &#x002B; 1&#x002B;&#x03B2;(m &#x002B; 1) &#x003E; 0, and thus for &#x03B2; <italic>&#x003D;</italic> &#x2212;1 we get <italic>n<sub>R</sub> &#x003E; m</italic>. In many immune models [5, 15, 20] this constraint is naturally realized because the internal variable is regulated by a much earlier step (m) than the output (<italic>n<sub>R</sub></italic>) within the same proofreading cascade.</p>
<p>To understand what happens for <italic>&#x03C4;</italic> &#x003C;&#x003C; <italic>&#x03C4;<sub>c</sub></italic>, it is more illuminating to compute ratio of responses</p>
<disp-formula id="ueqn1"><alternatives><graphic xlink:href="036293_ueqn1.gif"/></alternatives></disp-formula>
<disp-formula id="eqn11"><alternatives><graphic xlink:href="036293_eqn11.gif"/></alternatives></disp-formula>
<p>In models of immune detection based on proofreading such as adaptive sorting, <italic>f</italic> and <italic>g</italic> are powers of <italic>&#x03C4;</italic>, so that <italic>f</italic>(<italic>&#x03C4;</italic>)/<italic>f</italic>(<italic>&#x03C4;<sub>c</sub></italic>),<italic>g</italic>(<italic>&#x03C4;</italic>)/<italic>g</italic>(<italic>&#x03C4;<sub>c</sub></italic>) &#x003C;&#x003C; 1 when <italic>&#x03C4;</italic> &#x003C; <italic>&#x03C4;<sub>c</sub></italic>. So if &#x03B2; <italic>&#x003D;</italic> &#x2212;1, we see that <italic>&#x03C1; &#x2192;</italic> &#x002B; 1 when <italic>&#x03C4;</italic>/<italic>&#x03C4;<sub>c</sub> -&#x002B;</italic> 0, explaining why antagonism disappears in this parameter regime (corresponding to self in immune detection). Note that for <italic>f</italic> &#x221E; <italic>&#x03C4;</italic><sup><italic>nR</italic>&#x002B;1</sup> and <italic>g</italic> &#x221D; <italic>&#x03C4;</italic><sup><italic>m</italic>&#x002B;1</sup>, the leading order correction at small <italic>&#x03C4;</italic> is coming from the <italic>g</italic> term if <italic>n<sub>R</sub></italic> &#x003E; <italic>m</italic>, illustrated on <xref ref-type="fig" rid="fig4">Figure 4</xref>. Proofreading models interpolate between no antagonism for <italic>&#x03C4;</italic> &#x2192; 0 and linear antagonism close to threshold. Thus antagonism strength increases as <italic>&#x03C4;</italic> increases from 0, as observed experimentally [<xref ref-type="bibr" rid="c15">15</xref>], before quickly collapsing again very close to threshold. Quality of ligands <italic>&#x03C4;</italic> for maximum antagonism is closer to threshold <italic>&#x03C4;<sub>c</sub></italic> with increasing <italic>m</italic> and <italic>n<sub>R</sub> - m</italic> (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure"><label>FIG. 4.</label>
<caption><p>(Top) Computation of relative antagonism strength for different models with varying parameters. We consider <italic>L<sub>1</sub> &#x003D; L<sub>2</sub> &#x003D;</italic> 4 &#x00D7; 10 ligands, <italic>&#x03C4;<sub>c</sub></italic> &#x003D; 4, and plot 1 &#x2212; <italic>C</italic>{(<italic>L</italic><sub>1</sub>,<italic>&#x03C4;<sub>c</sub></italic>), (<italic>L</italic><sub>2</sub>,<italic>&#x03C4;</italic>)}/<italic>C</italic>(<italic>L</italic><sub>1</sub>,<italic>&#x03C4;<sub>c</sub></italic>). For instance, for homeo-static model, antagonism is <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline9.gif"/></alternatives></inline-formula>. Double arrow indicates region of inverted hierarchy for antagonism. Dotted squared highlight regions plotted on bottom panels. AS indicates adaptive sorting model similar to <xref ref-type="fig" rid="fig3">Figure 3 B</xref>, Immune model corresponds to model of <xref ref-type="fig" rid="fig3">Figure 3 C</xref>. (Bottom left). Log-log plot, showing the dependency of antagonism for small <italic>&#x03C4;</italic>. Dashed triangles indicate slopes of 1,2,3,4. For adaptive sorting models, slope is roughly equal to <italic>m</italic> &#x002B; 1 as expected from the form of <italic>g</italic>. (Bottom right) Linear plot close to <italic>&#x03C4; &#x003D; &#x03C4;<sub>c</sub></italic>. Aspect ratio has been chosen so that slope for the homeostatic model <italic>&#x2212;r</italic>/<italic>&#x03C4;<sub>c</sub></italic> is plotted with slope &#x2212;1. Dashed triangles indicate slopes of &#x2212;1,&#x2212;2. For adaptive sorting models, slopes are thus roughly equal to &#x2212;(<italic>N</italic> &#x2212; <italic>m</italic>)<italic>r</italic>/<italic>&#x03C4;<sub>c</sub></italic> as expected from the Ansatz.</p></caption>
<graphic xlink:href="036293_fig4.tif"/>
</fig>
<p>In conclusion, we have established the fundamental connection between ligand antagonism and absolute discrimination, the latter being a necessary by-product of the former, thus qualifying as a &#x201C;phenotypic spandrel&#x201D;. While there have been recent studies of spandrels at the level of protein structure [<xref ref-type="bibr" rid="c25">25</xref>], to our knowledge, this is the first study of an explicit spandrel structuring a complex signalling phenotype. With the exception of [<xref ref-type="bibr" rid="c26">26</xref>], our modelling hypotheses correspond to most phenotypic models of ligand discrimination we are aware of [<xref ref-type="bibr" rid="c10">10</xref>], as well as more complex models such as the one in [<xref ref-type="bibr" rid="c15">15</xref>]. Noise can be included as in [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c20">20</xref>] via time-integration of some output variable, replacing all concentrations by expectation values, e.g. <italic>C</italic> &#x2192; &#x003C; <italic>C</italic> &#x003E;. To possibly disentangle antagonism from absolute discrimination one would need to complexify formalism or hypotheses: for instance the time-course of a variable far from steady-state [<xref ref-type="bibr" rid="c26">26</xref>], coupled to multi stability [<xref ref-type="bibr" rid="c27">27</xref>] might be used. Discrimination might not be fully absolute and there might be additional modulations by ligand concentration or association rates [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c28">28</xref>]. However if <italic>&#x03C4;</italic> is the main discriminant for ligand quality as often hypothesized, this should only yield corrections to the leading order behaviour studied here.</p>
<p>The principles described can be applied to many pathways. We have already mentioned early recognition by T cells [<xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c20">20</xref>]. Another relevant immune example are Fc receptors, displaying similar hierarchy of binding time sensitivity, and an explicit mechanism for antagonism [<xref ref-type="bibr" rid="c14">14</xref>] where antagonists titrate the kinase responsible for proofreading steps, therefore realizing exactly the adaptive sorting network topology [<xref ref-type="bibr" rid="c5">5</xref>]. Antagonism mediated by similar feed-forward/feedback mechanisms has been described in other contexts, such as Hh signalling [<xref ref-type="bibr" rid="c29">29</xref>]. Hormonal pathways present response curves very reminiscent of a model for immune recognition [<xref ref-type="bibr" rid="c20">20</xref>], such as non-monotonic response activity with varying ligand concentration [<xref ref-type="bibr" rid="c19">19</xref>], that would correspond in our framework to approximate adaptation. It has been established that in such a context antagonists differ from agonists purely based on slower binding kinetics [<xref ref-type="bibr" rid="c30">30</xref>], further suggesting an absolute discrimination mechanism. A recent meta-study shows that most of these pathways indeed use internal negative feedbacks to change monotonicity of response [<xref ref-type="bibr" rid="c31">31</xref>] (possibly leading to endocrine disruption for non natural ligands). Other qualitative recognition processes may present similar properties: for instance antagonism is observed in olfaction [<xref ref-type="bibr" rid="c32">32</xref>]. Clearly more studies are needed to quantify both absolute quality of ligands and antagonism, but all these examples are possibly structured by similar spandrels as described here.</p>
<p>Is antagonism an evolutionary spandrel related to immune detection ? Networks evolved in [<xref ref-type="bibr" rid="c5">5</xref>] systematically show local biochemical adaptation and antagonism, as expected from the present derivation. So evolutionary spandrels can be observed and studied in evolutionary simulations, and their emergence studied theoretically. In nature, it is difficult to definitely know if a trait is a spandrel without detailed historical data and comparisons [<xref ref-type="bibr" rid="c33">33</xref>]. Other possibilities could be that absolute discrimination has been selected in conjunction with other properties (such as information transmission [<xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c35">35</xref>] or statistical decision [<xref ref-type="bibr" rid="c36">36</xref>]). But fundamentally, the presence of phenotypic spandrel here is due to the non-trivial computation performed by the cell to disentangle two parameters naturally tied by standard ligand-receptor interactions: kinetic of binding and ligand concentration. Experiments probing internal feedbacks (such as [<xref ref-type="bibr" rid="c14">14</xref>]) connect spandrels to cellular computations, similar to symmetries connected to physical laws.</p>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Audrey H Moores, Jean-Beno&#x00EE;t Lalanne and Gr&#x00E9;goire Altan-Bonnet for comments and discussions. This project has been funded by the Natural Science and Engineering Research Council of Canada (NSERC), Discovery Grant Program, and a Simons Investigator Award for Mathematical Modelling of Biological Systems to PF. LS was supported by an Undergraduate Summer Research Award from NSERC.</p>
</ack>
<app-group>
<app id="app"><label>APPENDIX</label>
<sec id="S1"><label>A.</label>
<title>Equations for adaptive sorting (AS)</title>
<p><disp-formula id="eqn12"><alternatives><graphic xlink:href="036293_eqn12.gif"/></alternatives></disp-formula>
<disp-formula id="eqn13"><alternatives><graphic xlink:href="036293_eqn13.gif"/></alternatives></disp-formula>
<disp-formula id="eqn14"><alternatives><graphic xlink:href="036293_eqn14.gif"/></alternatives></disp-formula>
where <italic>&#x03C6;<sub>m</sub> &#x003D; &#x03C6;<sub>K</sub>K</italic>,<italic>&#x03C6;<sub>N</sub> &#x003D; 0</italic> and <italic>&#x03C6;<sub>n</sub> &#x003D; &#x03C6;</italic> for other values of <italic>n</italic>.</p>
<p>Parameters used for simulation in main text are <italic>&#x03BA; &#x003D;</italic> 10<sup>&#x2212;5</sup>, <italic>R</italic> &#x003D; 3 x 10<sup>4</sup>,<italic>&#x03C6;</italic> &#x003D; <italic>&#x03C6;K<sub>T</sub> &#x003D;</italic> 0.09, <italic>C</italic><sup>&#x002A;</sup> &#x003D; 3, <italic>m</italic> &#x003D; 2, <italic>N</italic> &#x003D; 3. Output is <italic>C<sub>N</sub></italic>. We used <italic>&#x03C4;<sub>c</sub></italic> &#x003D; 4 <italic>s</italic> and defined threshold &#x0398; &#x003D; 0.31 to plot a discrimination line.</p>
<p>We get immediately at steady state
<disp-formula id="eqn15"><alternatives><graphic xlink:href="036293_eqn15.gif"/></alternatives></disp-formula>
setting <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline6.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline7.gif"/></alternatives></inline-formula>. Neglecting <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline8.gif"/></alternatives></inline-formula> in front of <italic>R</italic> we have</p>
<disp-formula id="eqn16"><alternatives><graphic xlink:href="036293_eqn16.gif"/></alternatives></disp-formula>
<p>Assuming <italic>&#x03C6;<sub>j</sub>&#x03C4;,&#x03BA;R&#x03C4;</italic> &#x003C;&#x003C; 1, we then get the following scaling laws for <italic>n &#x2264; m</italic>
<disp-formula id="eqn17"><alternatives><graphic xlink:href="036293_eqn17.gif"/></alternatives></disp-formula>
and for <italic>n &#x003E; m</italic>
<disp-formula id="eqn18"><alternatives><graphic xlink:href="036293_eqn18.gif"/></alternatives></disp-formula></p>
<p>Since <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline10.gif"/></alternatives></inline-formula>, we recover scaling law of the Ansatz from the main text.</p>
</sec>
<sec id="S2"><label>B.</label>
<title>Equations for immune model</title>
<disp-formula id="eqn19"><alternatives><graphic xlink:href="036293_eqn19.gif"/></alternatives></disp-formula>
<disp-formula id="eqn20"><alternatives><graphic xlink:href="036293_eqn20.gif"/></alternatives></disp-formula>
<p>Parameters used for simulation in main text are <italic>&#x03BA; &#x003D;</italic> 10<sup>&#x2212;4</sup>, <italic>R &#x003D;</italic> 3 &#x00D7; 10<sup>4</sup>, <italic>&#x03C6; &#x003D;</italic> 0.09, <italic>b</italic> &#x003D; 0.04, &#x03B3;<italic>S<sub>T</sub></italic> &#x003D; 0.72, <italic>C&#x2217; &#x003D;</italic> 300. Output is <italic>C<sub>N</sub></italic>. We used <italic>&#x03C4;<sub>c</sub></italic> &#x003D; 4 <italic>s</italic> and defined threshold &#x0398; &#x003D; 0.09 to plot a discrimination line.</p>
</sec>
<sec id="S3"><label>C.</label>
<title>Origin of linearity</title>
<p>Considering models defined above, it is clear that if we assume unsaturated receptors, <italic>i.e</italic>. <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline11.gif"/></alternatives></inline-formula>, calling <bold>C</bold> the vector of occupancies and <bold>M</bold> the internal variables, we have:</p>
<disp-formula id="eqn21"><alternatives><graphic xlink:href="036293_eqn21.gif"/></alternatives></disp-formula>
<p><bold>L</bold> &#x003D; (<italic>L</italic>, 0,&#x2026;, 0) is the vector corresponding to ligand input, <italic>&#x03BA;</italic>(<bold>M</bold>) the association rate of ligands to receptors - by definition here ligands and receptors bind into the first state <italic>C</italic><sub>0</sub>. <italic>T</italic>(<italic>R</italic>,<bold>M</bold>) is a matrix defining linear rates between occupancies states, depending on internal variables and parameter <italic>&#x03C4;</italic>. Dynamics and steady state value of <bold>M</bold> is given by extra equations that are model specific (e.g. <xref ref-type="disp-formula" rid="eqn12">equations 12</xref> and <xref ref-type="disp-formula" rid="eqn19">19</xref> above).</p>
<p>For such systems, we have at steady state
<disp-formula id="eqn22"><alternatives><graphic xlink:href="036293_eqn22.gif"/></alternatives></disp-formula>
from which we can directly compute the <italic>c<sub>j</sub></italic> as a function of <bold>M</bold>. Then we can use equations defining steady-state values of <bold>M</bold> as function of <bold>C</bold> to close the system.</p>
<p>When several ligand types are present, independence of ligand binding means that a system similar to <xref ref-type="disp-formula" rid="eqn21">equation 21</xref> holds for every single vector of occupancy <inline-formula><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="036293_inline12.gif"/></alternatives></inline-formula> of receptor states bound to ligands with quality <italic>&#x03C4;</italic>. Coupling between different types of ligands only occur via internal variables <bold>M</bold>. Note that we can also generalize this formalism so that transition rates depend on occupancies (i.e. effectively giving non linear transition rates between states) by assuming that internal variables <bold>M</bold> are occupancies themselves. The underlying strong assumption here is that the coupling is global, via total occupancies.</p>
</sec>
</app>
</app-group>
<ref-list>
<title>References</title>
<ref id="c1"><label>[1]</label><mixed-citation publication-type="journal"><string-name><given-names>O</given-names> <surname>Shoval</surname></string-name>, <string-name><given-names>H</given-names> <surname>Sheftel</surname></string-name>, <string-name><given-names>G</given-names> <surname>Shinar</surname></string-name>, <string-name><given-names>Y</given-names> <surname>Hart</surname></string-name>, <string-name><given-names>O</given-names> <surname>Ramote</surname></string-name>, <string-name><given-names>A</given-names> <surname>Mayo</surname></string-name>, <string-name><given-names>E</given-names> <surname>Dekel</surname></string-name>, <string-name><given-names>K</given-names> <surname>Kavanagh</surname></string-name>, and <string-name><surname>Uri</surname> <given-names>Alon</given-names></string-name>. <article-title>Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space</article-title>. <source>Science</source>, pages &#x2013;, April <year>2012</year>.</mixed-citation></ref>
<ref id="c2"><label>[2]</label><mixed-citation publication-type="journal"><string-name><surname>Aryeh</surname> <given-names>Warmflash</given-names></string-name>, <string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>, and <string-name><surname>Eric</surname> <given-names>D Siggia</given-names></string-name>. <article-title>Pareto evolution of gene networks: an algorithm to optimize multiple fitness objectives</article-title>. <source>Physical Biology</source>, <volume>9</volume>(<issue>5</issue>):<fpage>056001</fpage>&#x2013;<lpage>056001</lpage>, August <year>2012</year>.</mixed-citation></ref>
<ref id="c3"><label>[3]</label><mixed-citation publication-type="journal"><string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>. <article-title>Evolving phenotypic networks in sil-ico</article-title>. <source>Seminars in cell &#x0026; developmental biology</source>, <volume>35</volume>:<fpage>90</fpage>&#x2013;<lpage>97</lpage>, November <year>2014</year>.</mixed-citation></ref>
<ref id="c4"><label>[4]</label><mixed-citation publication-type="journal"><string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>, <string-name><surname>Vincent</surname> <given-names>Hakim</given-names></string-name>, and <string-name><surname>Eric</surname> <given-names>D Siggia</given-names></string-name>. <article-title>Deriving structure from evolution: metazoan segmentation</article-title>. <source>Molecular Systems Biology</source>, <volume>3</volume>:<issue>9</issue>, December <year>2007</year>.</mixed-citation></ref>
<ref id="c5"><label>[5]</label><mixed-citation publication-type="journal"><string-name><surname>Jean-Beno&#x00EE;t</surname> <given-names>Lalanne</given-names></string-name> and <string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>. <article-title>Principles of adaptive sorting revealed by in silico evolution</article-title>. <source>Physical Review Letters</source>, <volume>110</volume>(<issue>21</issue>):<fpage>218102</fpage>, May <year>2013</year>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label><mixed-citation publication-type="journal"><string-name><given-names>S J</given-names> <surname>Gould</surname></string-name> and <string-name><given-names>R C</given-names> <surname>Lewontin</surname></string-name>. <article-title>The spandrels of San Marco and the Panglossian paradigm: a critique of the adap-tationist programme</article-title>. <source>Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character</source>, <volume>205</volume>(<issue>1161</issue>):<fpage>581</fpage>&#x2013;<lpage>598</lpage>, September <year>1979</year>.</mixed-citation></ref>
<ref id="c7"><label>[7]</label><mixed-citation publication-type="journal"><string-name><given-names>S J</given-names> <surname>Gould</surname></string-name> and <string-name><given-names>E S</given-names> <surname>Vrba</surname></string-name>. <article-title>Exaptation-a missing term in the science of form</article-title>. <source>Paleobiology</source>, <year>1982</year>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label><mixed-citation publication-type="journal"><string-name><given-names>B</given-names> <surname>Malissen</surname></string-name>. <article-title>IMMUNOLOGY:Enhanced: Translating Affinity into Response</article-title>. <source>Science</source>, <volume>281</volume>(<issue>5376</issue>):<fpage>528</fpage>&#x2013;<lpage>529</lpage>, July <year>1998</year>.</mixed-citation></ref>
<ref id="c9"><label>[9]</label><mixed-citation publication-type="journal"><string-name><surname>Ofer</surname> <given-names>Feinerman</given-names></string-name>, <string-name><surname>Ronald</surname> <given-names>N Germain</given-names></string-name>, and <string-name><surname>Gr&#x00E9;goire</surname> <given-names>Altan-Bonnet</given-names></string-name>. <article-title>Quantitative challenges in understanding ligand discrimination by alphabeta T cells</article-title>. <source>Molecular immunology</source>, <volume>45</volume>(<issue>3</issue>):<fpage>619</fpage>&#x2013;<lpage>631</lpage>, February <year>2008</year>.</mixed-citation></ref>
<ref id="c10"><label>[10]</label><mixed-citation publication-type="journal"><string-name><surname>Melissa</surname> <given-names>Lever</given-names></string-name>, <string-name><surname>Philip</surname> <given-names>K Maini</given-names></string-name>, <string-name><given-names>P Anton</given-names> <surname>van der Merwe</surname></string-name>, and <string-name><surname>Omer</surname> <given-names>Dushek</given-names></string-name>. <article-title>Phenotypic models of T cell activation</article-title>. <source>Nature Reviews Immunology</source>, <volume>14</volume>(<issue>9</issue>):<fpage>619</fpage>&#x2013;<lpage>629</lpage>, August <year>2014</year>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label><mixed-citation publication-type="journal"><string-name><surname>Arup</surname> <given-names>K Chakraborty</given-names></string-name> and <string-name><surname>Arthur</surname> <given-names>Weiss</given-names></string-name>. <article-title>Insights into the initiation of TCR signaling</article-title>. <source>Nature immunology</source>, <volume>15</volume>(<issue>9</issue>):<fpage>798</fpage>&#x2013;<lpage>807</lpage>, August <year>2014</year>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label><mixed-citation publication-type="journal"><string-name><given-names>E N</given-names> <surname>Kersh</surname></string-name>, <string-name><given-names>A S</given-names> <surname>Shaw</surname></string-name>, and <string-name><surname>Paul</surname> <given-names>M Allen</given-names></string-name>. <article-title>Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation</article-title>. <source>Science</source>, <volume>281</volume>(<issue>5376</issue>):<fpage>572</fpage>&#x2013;<lpage>575</lpage>, July <year>1998</year>.</mixed-citation></ref>
<ref id="c13"><label>[13]</label><mixed-citation publication-type="journal"><string-name><given-names>N R</given-names> <surname>Gascoigne</surname></string-name>, <string-name><given-names>T</given-names> <surname>Zal</surname></string-name>, and <string-name><given-names>S M</given-names> <surname>Alam</surname></string-name>. <article-title>T-cell receptor binding kinetics in T-cell development and activation</article-title>. <source>Expert reviews in molecular medicine</source>, <volume>2001</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>, February <year>2001</year>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label><mixed-citation publication-type="journal"><string-name><given-names>C</given-names> <surname>Torigoe</surname></string-name>, <string-name><given-names>J K</given-names> <surname>Inman</surname></string-name>, and <string-name><given-names>H</given-names> <surname>Metzger</surname></string-name>. <article-title>An unusual mechanism for ligand antagonism</article-title>. <source>Science</source>, <year>1998</year>.</mixed-citation></ref>
<ref id="c15"><label>[15]</label><mixed-citation publication-type="journal"><string-name><surname>Gr&#x00E9;goire</surname> <given-names>Altan-Bonnet</given-names></string-name> and <string-name><surname>Ronald</surname> <given-names>N Germain</given-names></string-name>. <article-title>Modeling T Cell Antigen Discrimination Based on Feedback Control of Digital ERK Responses</article-title>. <source>PLoS Biology</source>, <volume>3</volume>(<issue>11</issue>):<fpage>e356</fpage>, November <year>2005</year>.</mixed-citation></ref>
<ref id="c16"><label>[16]</label><mixed-citation publication-type="journal"><string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name> and <string-name><surname>Eric</surname> <given-names>D Siggia</given-names></string-name>. <article-title>A case study of evolutionary computation of biochemical adaptation</article-title>. <source>Physical Biology</source>, <volume>5</volume>(<issue>2</issue>):<fpage>26009</fpage>, <year>2008</year>.</mixed-citation></ref>
<ref id="c17"><label>[17]</label><mixed-citation publication-type="journal"><string-name><surname>Wenzhe</surname> <given-names>Ma</given-names></string-name>, <string-name><surname>Ala</surname> <given-names>Trusina</given-names></string-name>, <string-name><surname>Hana</surname> <given-names>El-Samad</given-names></string-name>, <string-name><surname>Wendell</surname> <given-names>A Lim</given-names></string-name>, and <string-name><surname>Chao</surname> <given-names>Tang</given-names></string-name>. <article-title>Defining network topologies that can achieve biochemical adaptation</article-title>. <source>Cell</source>, <volume>138</volume>(<issue>4</issue>):<fpage>760</fpage>&#x2013;<lpage>773</lpage>, August <year>2009</year>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label><mixed-citation publication-type="journal"><string-name><surname>Timothy</surname> <given-names>W McKeithan</given-names></string-name>. <article-title>Kinetic Proofreading in T-Cell Receptor Signal-Transduction</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>92</volume>(<issue>11</issue>):<fpage>5042</fpage>&#x2013;<lpage>5046</lpage>, <year>1995</year>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label><mixed-citation publication-type="journal"><string-name><given-names>L N</given-names> <surname>Vandenberg</surname></string-name>, <string-name><given-names>T</given-names> <surname>Colborn</surname></string-name>, <string-name><given-names>T B</given-names> <surname>Hayes</surname></string-name>, <string-name><given-names>J J</given-names> <surname>Heindel</surname></string-name>, <string-name><given-names>D R</given-names> <surname>Jacobs</surname></string-name>, <string-name><given-names>D H</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>T</given-names> <surname>Shioda</surname></string-name>, <string-name><given-names>A M</given-names> <surname>Soto</surname></string-name>, <string-name><given-names>F S</given-names> <surname>vom</surname></string-name> Saal, <string-name><given-names>W V</given-names> <surname>Welshons</surname></string-name>, <string-name><given-names>R T</given-names> <surname>Zoeller</surname></string-name>, and <string-name><given-names>J P</given-names> <surname>Myers</surname></string-name>. <article-title>Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses</article-title>. <source>Endocrine Reviews</source>, <volume>33</volume>(<issue>3</issue>):<fpage>378</fpage>&#x2013;<lpage>455</lpage>, June <year>2012</year>.</mixed-citation></ref>
<ref id="c20"><label>[20]</label><mixed-citation publication-type="journal"><string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>, <string-name><surname>Guillaume</surname> <given-names>Voisinne</given-names></string-name>, <string-name><surname>Eric</surname> <given-names>D Siggia</given-names></string-name>, <string-name><surname>Gr&#x00E9;goire</surname> <given-names>Altan-Bonnet</given-names></string-name>, and <string-name><surname>Massimo</surname> <given-names>Vergassola</given-names></string-name>. <article-title>Phe-notypic model for early T-cell activation displaying sensitivity, specificity, and antagonism</article-title>. <source>Proc Natl Acad Sci U S A</source>, pages <fpage>1</fpage>&#x2013;<lpage>15</lpage>, February <year>2013</year>.</mixed-citation></ref>
<ref id="c21"><label>[21]</label><mixed-citation publication-type="journal"><string-name><given-names>B N</given-names> <surname>Dittel</surname></string-name>, <string-name><given-names>I</given-names> <surname>Stefanova</surname></string-name>, <string-name><given-names>R N</given-names> <surname>Germain</surname></string-name>, and <string-name><given-names>C A</given-names> <surname>Janeway</surname></string-name>. <article-title>Cross-antagonism of a T cell clone expressing two distinct T cell receptors</article-title>. <source>Immunity</source>, <volume>11</volume>(<issue>3</issue>):<fpage>289</fpage>&#x2013;<lpage>298</lpage>, September <year>1999</year>.</mixed-citation></ref>
<ref id="c22"><label>[22]</label><mixed-citation publication-type="other"><collab>Absolute discrimination for this model works even in the limit L &#x2192; 0, contrary to the more realistic immune inspired models presented in the following. However this comes at the cost of a speed-accuracy trade-off: from equations in <xref ref-type="fig" rid="fig1">Figure 1</xref> speed of convergence diverges as 1/L in this limit</collab>.</mixed-citation></ref>
<ref id="c23"><label>[23]</label><mixed-citation publication-type="journal"><string-name><surname>Simon</surname> <given-names>J Davis</given-names></string-name> and <string-name><given-names>P</given-names> <surname>Anton van der Merwe</surname></string-name>. <article-title>The kinetic-segregation model: TCR triggering and beyond</article-title>. <source>Nature immunology</source>, <volume>7</volume>(<issue>8</issue>):<fpage>803</fpage>&#x2013;<lpage>809</lpage>, August <year>2006</year>.</mixed-citation></ref>
<ref id="c24"><label>[24]</label><mixed-citation publication-type="journal"><string-name><given-names>S</given-names> <surname>Mangan</surname></string-name> and <string-name><surname>Uri</surname> <given-names>Alon</given-names></string-name>. <article-title>Structure and function of the feed-forward loop network motif</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>100</volume>(<issue>21</issue>):<fpage>11980</fpage>&#x2013;<lpage>11985</lpage>, October <year>2003</year>.</mixed-citation></ref>
<ref id="c25"><label>[25]</label><mixed-citation publication-type="journal"><string-name><surname>Michael</surname> <given-names>Manhart</given-names></string-name> and <string-name><surname>Alexandre</surname> <given-names>V Morozov</given-names></string-name>. <article-title>Protein folding and binding can emerge as evolutionary spandrels through structural coupling</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>112</volume>(<issue>6</issue>):<fpage>1797</fpage>&#x2013;<lpage>1802</lpage>, February <year>2015</year>.</mixed-citation></ref>
<ref id="c26"><label>[26]</label><mixed-citation publication-type="journal"><string-name><surname>Eric</surname> <given-names>D Siggia</given-names></string-name> and <string-name><surname>Massimo</surname> <given-names>Vergassola</given-names></string-name>. <article-title>Decisions on the fly in cellular sensory systems</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>110</volume>(<issue>39</issue>):E<fpage>3704</fpage>&#x2013;<lpage>12</lpage>, September <year>2013</year>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label><mixed-citation publication-type="journal"><string-name><surname>Tomasz</surname> <given-names>Lipniacki</given-names></string-name>, <string-name><surname>Beata</surname> <given-names>Hat</given-names></string-name>, <string-name><surname>James</surname> <given-names>R Faeder</given-names></string-name>, and <string-name><surname>William</surname> <given-names>S Hlavacek</given-names></string-name>. <article-title>Stochastic effects and bistability in T cell receptor signaling</article-title>. <source>Journal of Theoretical Biology</source>, <volume>254</volume>(<issue>1</issue>):<fpage>110</fpage>&#x2013;<lpage>122</lpage>, September <year>2008</year>.</mixed-citation></ref>
<ref id="c28"><label>[28]</label><mixed-citation publication-type="journal"><string-name><surname>Christopher</surname> <given-names>C Govern</given-names></string-name>, <string-name><surname>Michelle</surname> <given-names>K Paczosa</given-names></string-name>, <string-name><surname>Arup</surname> <given-names>K Chakraborty</given-names></string-name>, and <string-name><surname>Eric</surname> <given-names>S Huseby</given-names></string-name>. <article-title>Fast on-rates allow short dwell time ligands to activate T cells</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>107</volume>(<issue>19</issue>):<fpage>8724</fpage>&#x2013;<lpage>8729</lpage>, May <year>2010</year>.</mixed-citation></ref>
<ref id="c29"><label>[29]</label><mixed-citation publication-type="journal"><string-name><given-names>A M</given-names> <surname>Holtz</surname></string-name>, <string-name><given-names>K A</given-names> <surname>Peterson</surname></string-name>, <string-name><given-names>Y</given-names> <surname>Nishi</surname></string-name>, <string-name><given-names>S</given-names> <surname>Morin</surname></string-name>, <string-name><given-names>J Y</given-names> <surname>Song</surname></string-name>, <string-name><given-names>F</given-names> <surname>Charron</surname></string-name>, <string-name><given-names>A P</given-names> <surname>McMahon</surname></string-name>, and <string-name><given-names>B L</given-names> <surname>Allen</surname></string-name>. <article-title>Essential role for ligand-dependent feedback antagonism of vertebrate hedgehog signaling by PTCH1, PTCH2 and HHIP1 during neural patterning</article-title>. <source>Development (Cambridge, England)</source>, <volume>140</volume>(<issue>16</issue>):<fpage>3423</fpage>&#x2013;<lpage>3434</lpage>, July <year>2013</year>.</mixed-citation></ref>
<ref id="c30"><label>[30]</label><mixed-citation publication-type="journal">Rebecca <string-name><given-names>L</given-names> <surname>Rich</surname></string-name>, Lise <string-name><given-names>R</given-names> <surname>Hoth</surname></string-name>, <string-name><surname>Kieran</surname> <given-names>F Geoghegan</given-names></string-name>, <string-name><surname>Thomas</surname> <given-names>A Brown</given-names></string-name>, <string-name><surname>Peter</surname> <given-names>K LeMotte</given-names></string-name>, <string-name><surname>Samuel</surname> <given-names>P Simons</given-names></string-name>, <string-name><surname>Preston</surname> <given-names>Hensley</given-names></string-name>, and <string-name><surname>David</surname> <given-names>G Myszka</given-names></string-name>. <article-title>Kinetic analysis of estrogen receptor/ligand interactions</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>99</volume>(<issue>13</issue>):<fpage>8562</fpage>&#x2013;<lpage>8567</lpage>, June <year>2002</year>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label><mixed-citation publication-type="journal"><string-name><surname>Fabien</surname> <given-names>Lagarde</given-names></string-name>, <string-name><surname>Claire</surname> <given-names>Beausoleil</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>M Belcher</given-names></string-name>, <string-name><surname>Luc</surname> <given-names>P Belzunces</given-names></string-name>, <string-name><surname>Claude</surname> <given-names>Emond</given-names></string-name>, <string-name><surname>Michel</surname> <given-names>Guerbet</given-names></string-name>, and <string-name><surname>Christophe</surname> <given-names>Rousselle</given-names></string-name>. <article-title>Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment</article-title>. <source>Environmental Health</source>, <volume>14</volume>(<issue>1</issue>):<fpage>13</fpage>, <year>2015</year>.</mixed-citation></ref>
<ref id="c32"><label>[32]</label><mixed-citation publication-type="journal"><string-name><surname>Julia</surname> <given-names>Tsitron</given-names></string-name>, <string-name><surname>Addison</surname> <given-names>D Ault</given-names></string-name>, <string-name><surname>James</surname> <given-names>R Broach</given-names></string-name>, and <string-name><surname>Alexandre</surname> <given-names>V Morozov</given-names></string-name>. <article-title>Decoding complex chemical mixtures with a physical model of a sensor array</article-title>. <source>PLoS Com-put Biol</source>, <volume>7</volume>(<issue>10</issue>):<fpage>e1002224</fpage>&#x2013;<lpage>e1002224</lpage>, October <year>2011</year>.</mixed-citation></ref>
<ref id="c33"><label>[33]</label><mixed-citation publication-type="journal"><string-name><given-names>S J</given-names> <surname>Gould</surname></string-name>. <article-title>The exaptive excellence of spandrels as a term and prototype</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>94</volume>(<issue>20</issue>):<fpage>10750</fpage>&#x2013;<lpage>10755</lpage>, September <year>1997</year>.</mixed-citation></ref>
<ref id="c34"><label>[34]</label><mixed-citation publication-type="journal"><string-name><surname>Thierry</surname> <given-names>Mora</given-names></string-name>. <article-title>Physical Limit to Concentration Sensing Amid Spurious Ligands</article-title>. <source>Physical Review Letters</source>, <volume>115</volume>(<issue>3</issue>):<fpage>038102</fpage>, July <year>2015</year>.</mixed-citation></ref>
<ref id="c35"><label>[35]</label><mixed-citation publication-type="journal"><string-name><surname>Vijay</surname> <given-names>Singh</given-names></string-name> and <string-name><surname>Ilya</surname> <given-names>Nemenman</given-names></string-name>. <article-title>Accurate sensing of multiple ligands with a single receptor</article-title>. <source>arXiv.org</source>, May <year>2015</year>.</mixed-citation></ref>
<ref id="c36"><label>[36]</label><mixed-citation publication-type="journal"><string-name><surname>Jean-Beno&#x00EE;t</surname> <given-names>Lalanne</given-names></string-name> and <string-name><surname>Paul</surname> <given-names>Fran&#x00E7;ois</given-names></string-name>. <article-title>Chemodetection in fluctuating environments: Receptor coupling, buffering, and antagonism</article-title>. <source>Proc Natl Acad Sci U S A</source>, January <year>2015</year>.</mixed-citation></ref>
</ref-list>
</back>
</article>